Case Study: A Diagnostic Challenge Involving Metachronous Pancreatic Metastasis from High-Grade Serous Ovarian Carcinoma
-
By
-
Bahaaeldin Baraka
-
Maryam Al-Ani
-
Adam Afife
-
Irshad Soomro
-
Srinivasan Madhusudan
-
August 12, 2026
Clinical Scorecard: Case Study: A Diagnostic Challenge Involving Metachronous Pancreatic Metastasis from High-Grade Serous Ovarian Carcinoma
At a Glance
| Category | Detail |
|---|
| Condition | Metachronous Pancreatic Metastasis from Ovarian Cancer |
| Key Mechanisms | Metastasis primarily through transcoelomic, lymphatic, or hematogenous routes. |
| Target Population | Patients with high-grade serous ovarian carcinoma. |
| Care Setting | Oncology and multidisciplinary care teams. |
Key Highlights
- Pancreatic metastases from ovarian cancer are infrequent and present diagnostic challenges.
- Histological evidence is crucial for confirming pancreatic metastasis.
- Treatment strategies include surgical excision and chemotherapy.
- CA125 levels are used for monitoring disease progression.
- Multidisciplinary team discussions are essential for management decisions.
Guideline-Based Recommendations
Diagnosis
- Histological confirmation of pancreatic metastasis is required.
Management
- Neoadjuvant chemotherapy followed by optimal debulking surgery is recommended.
Monitoring & Follow-up
- Regular imaging and CA125 level assessments are necessary for monitoring.
Risks
- Potential for recurrence and complications from treatment.
Patient & Prescribing Data
Women diagnosed with high-grade serous ovarian carcinoma.
Combination chemotherapy with carboplatin, paclitaxel, and bevacizumab is utilized.
Clinical Best Practices
- Engage multidisciplinary teams for comprehensive management.
- Utilize imaging and CA125 levels for ongoing monitoring.
- Consider individual patient factors when determining treatment plans.
Related Resources & Content
